Latest news
Loading news…
Tacalyx
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Berlin, Germany Founded 2019 1-10 employees For Profit
Tacalyx is a biotech company that develops therapies that target cancer by focusing on tumor-associated carbohydrate antigens.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $288K
Company Info
- Founded
- 2019
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 11
- HQ
- Berlin, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- High
- Trend (7d)
- -0.2
- Trend (30d)
- -3
- Trend (90d)
- 5.2
- Last leadership hire
- Dec 2, 2025
Key People at Tacalyx
CSO & Co-founder
Chief Executive Officer
Co-Founder
5
professional contacts at Tacalyx
Contact execs at Tacalyx →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Tacalyx
Loading news…
FAQs about Tacalyx
People who checked this page also checked these
Browse the full Acquirezy directory.